Nektar Therapeutics (NKTR)
NASDAQ·Healthcare·Biotechnology
$70.62
-0.42%
Mkt Cap $1.35B
Analyst Ratings
Buy
8
Hold
2
Sell
0
Price Target (17 analysts)
$150.17
Range $80.00 – $192.00
Implied Upside
+112.6%
Consensus $150.17 vs current $70.62
NASDAQ·Healthcare·Biotechnology
$70.62
-0.42%
Mkt Cap $1.35B
Buy
8
Hold
2
Sell
0
Price Target (17 analysts)
$150.17
Range $80.00 – $192.00
+112.6%
Consensus $150.17 vs current $70.62